MDGL Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH).

$66.21  +1.44 (2.22%)
As of 10/04/2022 12:38:49 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/06/2007
Outstanding shares:  17,103,395
Average volume:  274,302
Market cap:   $1,111,549,641
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BD59BS7
Valuation   (See tab for details)
PE ratio:   -5.85
PB ratio:   7.60
PS ratio:   0.00
Return on equity:   -169.35%
Net income %:   -1,338,904.83%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy